The AMR Industry Alliance is one of the largest private sector coalitions set up to provide sustainable solutions to curb antimicrobial resistance, with over 100 biotech, diagnostics, generics and research-based pharmaceutical companies and associations joining forces.
Antimicrobial resistance poses a formidable threat to the attainment of the Sustainable Development Goals (SDGs).
The United Nations called in 2016 for concerted action from governments and various sectors to address the implications of antimicrobial resistance in a comprehensive manner, and implement strategies at national level.
We measure and drive the life-sciences industry progress to curb antimicrobial resistance in four different areas:
The AMR Industry Alliance is the life-sciences industry response to the call for action.